Cara Manmeet Bhuller, Michael Bau Mortensen, Henriette Engberg, Claus Wilki Fristrup
{"title":"Validity of the Pancreatic Cancer Registry in Southern Denmark.","authors":"Cara Manmeet Bhuller, Michael Bau Mortensen, Henriette Engberg, Claus Wilki Fristrup","doi":"10.61409/A08240545","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The Danish Pancreatic Cancer Database (DPCD) uses data from the Danish National Patient Registry (DNPR) and includes patients with pancreatic carcinomas, duodenal and ampullary cancers. Due to the aggressive nature of pancreatic cancer, some patients never receive diagnostic work-up at a hepato-pancreatico-biliary centre. The aim of this study was to explore the validity of the registration of the pancreatic cancer diagnosis for patients living in the Region of Southern Denmark reported in the DNPR but not included in the DPCD.</p><p><strong>Methods: </strong>This study is a descriptive analysis of a historical cohort of patients registered with a diagnosis of pancreatic cancer (DC 25.0-25.9, DC 24.1, DC 17.0, excluding DC 25.4) from 1 July 2019 to 30 June 2022, in the DNPR but with no registration in the DPCD.</p><p><strong>Results: </strong>We identified 155 patients with a relevant diagnosis in the DNPR who were not included in the DPCD. A total of 62 patients (40%) represented potentially valid cases of pancreatic cancer, whereas 73 patients (47%) had pNET and 20 patients (13%) had an entirely different diagnosis. Only seven patients (11%) of the potentially valid pancreatic cancer group and 4.5% of the total study cohort had a histology-verified diagnosis of pancreatic cancer. The DNPR contained (93/944) 10% with an incorrect diagnosis of pancreatic cancer and 6% with an uncertain diagnosis.</p><p><strong>Conclusions: </strong>This study demonstrates a high level of completeness for the DPCD in the Region of Southern Denmark. Invalid registration of the pancreatic cancer diagnosis is an important limitation in using the DNPR, which is the only data source for identifying patients with pancreatic cancer in Denmark.</p><p><strong>Funding: </strong>None.</p><p><strong>Trial registration: </strong>Not relevant.</p>","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"72 3","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A08240545","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The Danish Pancreatic Cancer Database (DPCD) uses data from the Danish National Patient Registry (DNPR) and includes patients with pancreatic carcinomas, duodenal and ampullary cancers. Due to the aggressive nature of pancreatic cancer, some patients never receive diagnostic work-up at a hepato-pancreatico-biliary centre. The aim of this study was to explore the validity of the registration of the pancreatic cancer diagnosis for patients living in the Region of Southern Denmark reported in the DNPR but not included in the DPCD.
Methods: This study is a descriptive analysis of a historical cohort of patients registered with a diagnosis of pancreatic cancer (DC 25.0-25.9, DC 24.1, DC 17.0, excluding DC 25.4) from 1 July 2019 to 30 June 2022, in the DNPR but with no registration in the DPCD.
Results: We identified 155 patients with a relevant diagnosis in the DNPR who were not included in the DPCD. A total of 62 patients (40%) represented potentially valid cases of pancreatic cancer, whereas 73 patients (47%) had pNET and 20 patients (13%) had an entirely different diagnosis. Only seven patients (11%) of the potentially valid pancreatic cancer group and 4.5% of the total study cohort had a histology-verified diagnosis of pancreatic cancer. The DNPR contained (93/944) 10% with an incorrect diagnosis of pancreatic cancer and 6% with an uncertain diagnosis.
Conclusions: This study demonstrates a high level of completeness for the DPCD in the Region of Southern Denmark. Invalid registration of the pancreatic cancer diagnosis is an important limitation in using the DNPR, which is the only data source for identifying patients with pancreatic cancer in Denmark.
期刊介绍:
The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content.
DMJ will publish the following articles:
• Original articles
• Protocol articles from large randomized clinical trials
• Systematic reviews and meta-analyses
• PhD theses from Danish faculties of health sciences
• DMSc theses from Danish faculties of health sciences.